Antigen Escape News Today

Delve into the challenges of CAR T-cell therapy access and explore the biology behind treatment responses and relapses in lymphoma patients.

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are part of an international team of scientists who identified mechanisms by which some multiple myelomas become resistant to initially effective T-cell therapies.